Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FCN-411 in Advanced Non-small Cell Lung Cancer
NCT03420079Phase 2Unknown
- Sponsor
- Jinzhou Ahon Pharmaceutical Co., Ltd.
- Start
- Aug 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of FCN-411 in non-small cell lung cancer (NSCLC), sponsored by Jinzhou Ahon Pharmaceutical Co., Ltd.. Status: unknown.
02
Drugs
FCN-411
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03420079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03420079.